GTC

General Terms and Conditions (GTC)

1 Product description and application 

CATUVAB is a class IIb medical device according to the Medical Device Regulation (EU) 2017/745, developed by Lindis Blood Care GmbH. It is used for the extracorporeal removal of EpCAM-positive tumor cells from the blood by means of intraoperative blood salvage (IOS) and additional filtration. The goal is to safely transfuse the autologous erythrocyte concentrate back into the patient. CATUVAB is used in particular for operations with expected blood loss of more than 400 ml and is aimed at hospitals and in-patient facilities that treat patients with EpCAM-positive tumors. It is used exclusively by qualified medical personnel in accordance with the instructions for use (version 04 dated 21.02.2024 or the latest version). 

1.1 The scope of delivery of the CATUVAB kit includes the following components: 

  • A prefilled ready-to-use syringe (CATUVAB PFS) containing 10 μg catumaxomab antibody in 0.1 ml water for injection, consisting of a glass syringe barrel, stopper, luer lock closure, cap, tear-off label, and plunger rod, 
  • one vial with 5.7 ml 0.9 % NaCl solution (dilution buffer), 
  • two 2 ml syringes without needle, 
  • a 27 G cannula for the antibody syringe and 
  • a 21 G cannula for withdrawing the diluted antibody solution. 

2 Scope of application

2.1 These General Terms and Conditions (“GTC”) apply to all sales of the medical device CATUVAB by Lindis Blood Care GmbH (“Seller”) to clinics, in-patient facilities and wholesalers (“Purchaser”). The Seller‘s General Terms and Conditions shall apply exclusively to traders within the meaning of Section 310 (1) of the German Civil Code (Bürgerliches Gesetzbuch – BGB). 

2.2 Deviating or supplementary contractual terms and conditions of the Purchaser shall only become part of the contract if the Seller expressly agrees to them in writing. This shall also apply if the Seller carries out deliveries without objection or if the Purchaser refers to its own terms and conditions. 

3 Conclusion of contract

3.1 Offers made by the Seller are subject to change and non-binding. A contract is only concluded when the Purchaser places a written order (by post, e-mail or fax) and the Seller confirms the order. 

3.2 The Purchaser must check the order confirmation within 5 working days of receipt and raise any objections in writing. Otherwise, the order shall be deemed to have been bindingly confirmed.

4 Delivery and devolution of risk

4.1 Unless otherwise stated in the order confirmation, delivery EXW Henningsdorf (in accordance with Incoterms 2020 or the respective current version) is agreed. This shall also apply if the Seller has assumed the transportation costs or disbursed them for the Purchaser or if partial deliveries are made. 

4.2 Deviations from the scope of delivery (see 1.1) are possible. However, the intended use remains ensured. 

4.3 Delivery dates are non-binding unless they have been expressly agreed in writing between the parties as binding. 

4.4 If the goods cannot be dispatched for reasons for which the Purchaser is responsible, the Seller is entitled to store the goods at the Purchaser‘s risk and expense. In such cases, the date of storage shall be deemed to be the delivery date; the warehouse receipt shall replace the shipping documents. 

5 Prices and terms of payment

5.1 The prices are net prices in euros plus the applicable value added tax. Packaging, shipping and insurance costs shall be charged separately to the Purchaser, unless otherwise agreed. 

5.2 Payments are due within 30 days of the invoice date without deduction. A discount deduction may only be deducted in accordance with the relevant information on the invoice. The date of receipt of payment by the Seller or the date of crediting to one of its bank accounts shall be deemed to be the date of payment for the discount deduction. 

5.3 Default interest of 9 percentage points above the base rate of interest shall be charged in the event of late payment. The Seller reserves the right to withhold further deliveries until outstanding amounts have been settled. 

6 Retention of title

6.1 The goods shall remain the property of the Seller until the purchase price has been paid in full. 

6.2 The Purchaser is entitled to use the goods in the ordinary course of business (e.g. for patient treatment) but may neither pledge them nor assign them as security. In the event of seizure or other access by third parties, the Purchaser must inform the Seller immediately. 

6.3 If the goods delivered by the Seller are resold as intended or transferred to third parties for any other legal reason before the purchase price has been paid in full, the Purchaser hereby assigns to the Seller all claims against its customers arising from the resale of the reserved goods, including all ancillary rights, to secure the outstanding purchase price claims. If the goods are processed, combined or mixed as intended, the assignment shall be in the amount of the invoice value of the Seller‘s goods used in the process. If the value of the securities existing for the Seller exceeds the secured claim by more than ten (10) percent in total, the Seller undertakes to release securities of its choice at the Purchaser‘s request. 

7 Warranty and liability

7.1 The statutory provisions shall apply to the Purchaser‘s rights in the event of material defects and defects of title, unless otherwise specified below. 

7.2 Quality agreements are possible between Seller and Purchaser and are decisive for the target quality of the goods. They must be agreed in writing between the parties. 

7.3 Obvious defects in the goods must be reported in writing within seven (7) days of receipt of the goods, hidden defects must be reported within seven (7) days of their discovery. Otherwise, the goods shall be deemed approved. In the event of justified defects, the Seller shall, at its discretion, provide subsequent performance (rectification or replacement delivery). 

7.4 Warranty rights shall lapse if CATUVAB has not been used as intended, has been stored improperly (e.g. outside +2 °C to +8 °C) or has been tampered with. 

7.5 The liability of the Seller, its legal representatives or vicarious agents is limited to intent and gross negligence. In the event of slight negligence, the Seller shall only be liable for the breach of material contractual obligations, whereby liability for financial losses in this case shall be limited to the damage foreseeable at the time of conclusion of the contract and typical for the contract. Essential contractual obligations are those whose fulfillment is essential for the proper execution of the contract and on whose compliance the Purchaser may regularly rely. Liability for damage to life, body or health as well as for claims arising from mandatory statutory provisions, in particular the Product Liability Act and Regulation (EU) 2017/745, remains unaffected. 

8 Return and disposal

8.1 The return of goods is only possible in the event of defects, incorrect deliveries or expiry of the expiry date prior to delivery with the Seller‘s prior written consent. The return shipment shall be at the Purchaser‘s expense and risk. 

8.2 The Purchaser shall dispose of CATUVAB in accordance with the respective local regulations for biologically contaminated medical devices. Biologically contaminated components must be disposed of in the containers provided for this purpose. Non-contaminated components must be disposed of in accordance with local recycling or waste disposal regulations. 

9 Confidentiality

9.1 The Purchaser undertakes not to disclose confidential information about CATUVAB to third parties, unless this is necessary in individual cases for the intended use (e.g. training of personnel) and the third party concerned is subject to equivalent confidentiality obligations. Confidential information includes all non-public data relating to CATUVAB, including, but not limited to, technical specifications, kit composition, manufacturing processes, application techniques, pricing, business strategies and any other information that the Seller has designated as confidential or that is customarily considered confidential in nature and scope. 

9.2 The Purchaser is obliged to secure confidential information by means of appropriate electronic protection mechanisms. This includes in particular the use of current encryption technologies, access restrictions through password protection or authentication systems as well as the regular updating of security software to prevent unauthorized access, loss or unauthorized disclosure of the information. 

9.3 The obligations under 9.1 and 9.2 shall continue to apply for 10 years after termination of the contractual relationship. 

10 Force majeure

10.1 Cases of force majeure that prevent the Seller from fulfilling its obligations in whole or in part shall release the Seller and Purchaser from the fulfillment of the respective contractual obligations until the force majeure ceases. 

10.2 Force majeure shall mean all circumstances beyond the Seller‘s control, in particular natural events, explosion, fire, accident, war and comparable hostilities, refusal to grant licenses or permits, as well as prohibitions or measures of any kind by a government authority, including in the context of combating a pandemic. 

10.3 Seller and Purchaser shall determine by mutual agreement whether all activities that were not carried out during this period are to be made up for after the end of the force majeure. 

10.4 If the force majeure lasts longer than 60 days, Seller and Purchaser are entitled to withdraw from the contract. 

11 Data protection 

The Seller processes personal data exclusively in compliance with data protection regulations. Information on the processing of personal data is contained in the „Privacy Policy of Lindis Blood Care“. These are available at Privacy Policy. 

12 Applicable law and place of jurisdiction

12.1 German law shall apply to the exclusion of the UN Convention on Contracts for the International Sale of Goods (CISG). 

12.2 The exclusive place of jurisdiction for all disputes arising from or in connection with this contract is Berlin, insofar as the Purchaser is a trader, a legal entity under public law or a special fund under public law. 

13 Export control

13.1 The Seller shall make deliveries provided that no national or international regulations – in particular export control laws, embargoes or other sanction regulations – prevent the fulfillment of the contract. The Purchaser shall provide all information and documents necessary for the export, shipment or import. Any delays due to export controls or necessary approval procedures shall result in the agreed delivery periods and dates being canceled. If necessary approvals are not granted in individual cases, the contract shall be deemed not concluded with regard to the delivery or service concerned. 

13.2 The Purchaser undertakes not to sell, export, re-export or otherwise make available for use, either directly or indirectly, any goods delivered under this contract that fall under the respective applicable versions of Regulations (EU) No. 833/2014 or No. 765/2006 (so-called critical goods) in the Russian Federation or Belarus. 

13.3 The Purchaser is prohibited from using or making available to third parties any intellectual property rights, trade secrets and other materials or information protected by intellectual property rights or considered confidential information in connection with common high priority items listed in Regulation (EU) No 833/2014, if such goods are to be directly or indirectly supplied, exported or used in the Russian Federation. 

14 Miscellaneous

14.1 Amendments or additions to these GTC must be made in writing. This also applies to the waiver of the written form requirement. 

14.2 Should any provision of these GTC be or become invalid, this shall not affect the validity of the remaining provisions. The parties undertake to replace the invalid provision with a valid provision that comes as close as possible to the economic purpose of the invalid provision.